ARTICLE | Emerging Company Profile
The choice between yttrium and iodine
September 23, 1996 7:00 AM UTC
Coulter & Idec
While Coulter believes there is a place for yttrium in cancer therapy, potentially against solid tumors, the company considers iodine to be a better choice for lymphomas because penetration of the antibody into tissues isn't an issue and myelosuppression is a significant risk with yttrium...